STORM-PE

Clinical Trial Title

NCT05684796

National Clinical Trial Number:

STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation plus Mechanical Aspiration with the Indigo® Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism

Contact Information

Karl Villanueva, MS, CCRP

Call (312) 563-7305

Send Email

Clinical Trial Protocol Description:

Patients with suspected intermediate-high risk acute pulmonary embolism (PE) receiving treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System. Patients can expect to be followed for 90 days after procedure.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

Have clinical signs and symptoms of acute intermediate- high risk PE within 14 days confirmed by CTPA imaging.

You will be excluded from the study if any of the following criteria apply to you:

Have active cancer and are receiving treatment within the last 6 months will not be eligible for this study.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.